Duane Burnett

Duane Burnett, PhD, Chief Technology Officer

Duane is a drug discovery leader with over 30 years of experience at top pharmaceutical companies including Schering-Plough, Merck and FORUM Pharmaceuticals working primarily in CNS and cardiovascular drug discovery. During his career as a medicinal chemist, he has garnered an impressive list of awards: National Inventor of the Year (2005), Prix Galien USA – Best Medical Agent Finalist (2011), American Chemical Society Hero of Chemistry Award (2004), Thomas Alva Edison Patent Award (2002). In addition, he has 60 published papers and more than 110 granted or published patents and applications. He is best known as an inventor of the cholesterol absorption inhibitor ezetimibe, used in two highly successful, multi-billion dollar products for treating hypercholesterolemia. Duane received his PhD in Organic Chemistry from The Ohio State University and conducted postdoctoral research at the University of Utah.